A 16-week regimen was effective in patients with HCV genotype 1 infection who previously failed an NS5A/sofosbuvir-based treatment regimen. Source link
[ad_1] Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients Source link [ad_1]
High rates of virologic suppression were seen in treatment-experienced adults who switched to BIC/FTC/TAF, regardless of preexisting resistance to NRTIs. Source link
© 2017 Worldnews Media LLC. All Rights Reserved.